Li Med Labs Private Limited, a active private limited company, was established on 26 June 2018 in Thiruvananthapuram, Kerala, India. Engaging in pharma contract r&d within the hospital and medical care sector, it holds CIN: U74999KL2018PTC053797. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.10 M.
It upholds a compliant status. Its leadership includes Rineeshamol Abdul Rahman (Director), Shafi Puzhakkarayil Ayush (Whole-Time Director), Hussain Maliyackal Sithara (Director). Past directors included Shafi Puzhakkarayil Ayush, Ajmal Puzhakarayil Shafi, Gopalakrishnapillai Anish. It holds ₹7.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ushus, House No.617, Andoor, Enikkara, Karakulam P.O, Thiruvananthapuram, Kerala, 695564.
U74999KL2018PTC053797
053797
26 June 2018
₹5.00 M
₹1.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Li Med Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rineeshamol Abdul Rahman | Director | 15 Apr 2021 | Current |
| Shafi Puzhakkarayil Ayush | Whole-Time Director | 05 Feb 2019 | Current |
| Hussain Maliyackal Sithara | Director | 05 Feb 2019 | Current |
| Sumaiya Aasmi | Director | 05 Feb 2019 | Current |
| Vadakkencherry Ramanathan Sangeetha | Director | 26 Jun 2018 | Current |
| Gopalakrishnapillai Anish | Whole-Time Director | 05 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jul 2022 | Past |
| Pramod Abcsdd | Director | 17 May 2022 | Past |
| Pramod Abcsdd | Director | 18 Jul 2022 | Past |
| Pramod Abcsdd | Director | 18 Jul 2022 | Past |
| Pramod Abcsdd | Director | 18 Jul 2022 | Past |
| Pramod Abcsdd | Director | 18 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Li Med Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 73.28% increase. The company also saw a substantial improvement in profitability, with a 188.25% increase in profit. The company's net worth Soared by an impressive increase of 84.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Li Med Labs had a public holding of 81.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2020 | Others | ₹7.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Li Med Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Li Med Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Li Med Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Li Med Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Li Med Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
Progress on A charge with Others of Rs. 7.50 M registered on 03 Feb 2020 with Charge ID 100325380 was modified on 10 Nov 2022. was documented.
Progress on Rineeshamol Abdul Rahman was appointed as a Director was appointed as a Director on 15 Apr 2021 & has been associated with this company since 4 years 8 months . was documented.
Progress on A charge with Others amounted to Rs. 7.50 M with Charge ID 100325380 was registered on 03 Feb 2020. was documented.
Shafi Puzhakkarayil Ayush was appointed as a Whole-time director was appointed as a Whole-time director on 05 Feb 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
The CIN of Li Med Labs Private Limited is U74999KL2018PTC053797.
Li Med Labs Private Limited is headquartered at Ushus, House No.617, Andoor, Enikkara, Karakulam P.O, Thiruvananthapuram, Kerala, 695564.
Li Med Labs Private Limited was incorporated on 26 June 2018.
The current directors of Li Med Labs Private Limited are
The primary industry of Li Med Labs Private Limited is Hospital And Medical Care.
Li Med Labs Private Limited is unlisted.
The authorized capital of Li Med Labs Private Limited is ₹5.00 M, and the paid-up capital is ₹1.10 M.
The compliance status of Li Med Labs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX